Armando Caballero López
Research Subjects
Armando Caballero López has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Agustín Lage Dávila
Clinical Immunology Department, Center of Molecular Immunology, Havana 11600, Cuba
1 shared publication - Amed Leiva Mederos
Universidad Central “Marta Abreu” de Las Villa
1 shared publication - Armando David Caballero Font1 shared publication
- Carlos Herrera
Departamento de Medicina Intensiva. Hospital Universitario Arnaldo Milián Castro. Villa Clara. Cuba. Departamento de Medicina Intensiva. Hospital Universitario Manuel Fajardo. Villa Clara. Cuba
1 shared publication - César Fidel Sánchez Valdés
Departamento de Física y Matemáticas, Extensión Multidisciplinaria en Ciudad Universitaria, Instituto de Ingeniería y Tecnología, Universidad Autónoma de Ciudad Juárez, Ciudad Juárez 32310, Chihuahua, Mexico
1 shared publication - Elibet Chávez-González
Electrophysiology Department, Cardiocentro Ernesto Che Guevara, Santa Clara, Cuba
1 shared publication
Latest Publications
- 3 February 2026
- Published by Springer Nature
- p. 178-191
An Approach to Generating Knowledge-Based Explanations: A Case Study in Health
- 3 February 2026
- Published by Springer Nature
- p. 178-191
An Approach to Generating Knowledge-Based Explanations: A Case Study in Health
- Open Access
- 10 August 2021
- Published by Universidad Autonoma de Chile in International Journal of Medical and Surgical Sciences
- Vol. 8 (3) , 1-15
Variables associated with severity in COVID-19 patients
In COVID-19, a percentage of patients develop severe disease, with high mortality, since has been necessary to study its characteristics to stop the progression of the disease. A retrospective study was carried out in a cohort of 150 adult patients attended at Manuel Fajardo Hospital in Villa Clara, Cuba, from March to June 2020. Demographic, clinical, laboratory, gasometric and radiological variables measured at hospital admission were analyzed, defining two groups of patients according to clinical evolution: severe and non-severe. For the comparison of the groups a bivariate analysis was performed, with the objective of determining those variables with a significant association to severity. Of the total number of patients, 26 (17.3%) evolved to severity and 124 (83.7%) evolved satisfactorily. Severe patients were characterized by advanced age (mean: 83 years) and comorbidities; the most significant being hypertension, diabetes mellitus, heart disease, chronic kidney disease and cancer (p< 0.0001). Polypnea and diarrhea were the clinical manifestations with the highest association with severity (p<0.0001), followed by fever (p=0.0157). The quick SOFA prognostic scale proved to be a useful instrument to evaluate patients at admission. Laboratory variables: neutrophils, lymphocytes, neutrophil/lymphocyte ratio, hemoglobin and lactate dehydrogenase were the most associated with severity (p<0.0001). Leukocytes, lactate, D-dimer, C-reactive protein, glycemia and calcium also showed significant results (p<0.05). Of the gasometric variables, arterial oxygen pressure and saturation were the most significantly associated with severity; as well as the presence of pulmonary infiltrates or consolidation in the chest X-ray (p<0.0001). The study allowed us to identify variables at hospital admission associated with progression to severe forms of the disease.
- 10 August 2021
- Published by Universidad Autonoma de Chile in International Journal of Medical and Surgical Sciences
- Vol. 8 (3) , 1-15
Open AccessVariables associated with severity in COVID-19 patients
In COVID-19, a percentage of patients develop severe disease, with high mortality, since has been necessary to study its characteristics to stop the progression of the disease. A retrospective study was carried out in a cohort of 150 adult patients attended at Manuel Fajardo Hospital in Villa Clara, Cuba, from March to June 2020. Demographic, clinical, laboratory, gasometric and radiological variables measured at hospital admission were analyzed, defining two groups of patients according to clinical evolution: severe and non-severe. For the comparison of the groups a bivariate analysis was performed, with the objective of determining those variables with a significant association to severity. Of the total number of patients, 26 (17.3%) evolved to severity and 124 (83.7%) evolved satisfactorily. Severe patients were characterized by advanced age (mean: 83 years) and comorbidities; the most significant being hypertension, diabetes mellitus, heart disease, chronic kidney disease and cancer (p< 0.0001). Polypnea and diarrhea were the clinical manifestations with the highest association with severity (p<0.0001), followed by fever (p=0.0157). The quick SOFA prognostic scale proved to be a useful instrument to evaluate patients at admission. Laboratory variables: neutrophils, lymphocytes, neutrophil/lymphocyte ratio, hemoglobin and lactate dehydrogenase were the most associated with severity (p<0.0001). Leukocytes, lactate, D-dimer, C-reactive protein, glycemia and calcium also showed significant results (p<0.05). Of the gasometric variables, arterial oxygen pressure and saturation were the most significantly associated with severity; as well as the presence of pulmonary infiltrates or consolidation in the chest X-ray (p<0.0001). The study allowed us to identify variables at hospital admission associated with progression to severe forms of the disease.